Switch to:
Haemonetics Corp (NYSE:HAE)
EV/EBIT
-65.63 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its Earnings Before Interest and Taxes (EBIT). As of today, Haemonetics Corp's enterprise value is $1,762.4 Mil. Haemonetics Corp's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2015 was $-26.9 Mil. Therefore, Haemonetics Corp's EV/EBIT ratio for today is -65.63.

During the past 13 years, the highest EV/EBIT Ratio of Haemonetics Corp was 76.40. The lowest was -78.70. And the median was 16.40.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Haemonetics Corp's enterprise value for the quarter that ended in Dec. 2015 was $1,959.7 Mil. Haemonetics Corp's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2015 was $-26.9 Mil. Haemonetics Corp's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2015 was -1.37%.


Definition

Haemonetics Corp's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Earnings Before Interest and Taxes (EBIT) (TTM)
=1762.367/-26.854
=-65.63

Haemonetics Corp's current Enterprise Value is $1,762.4 Mil.
Haemonetics Corp's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2015 was 11.538 (Mar. 2015 ) + 3.606 (Jun. 2015 ) + 19.179 (Sep. 2015 ) + -61.177 (Dec. 2015 ) = $-26.9 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Haemonetics Corp's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2015 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Dec. 2015 )=EBIT (TTM)/Enterprise Value (Q: Dec. 2015 )
=-26.854/1959.732
=-1.37 %

Haemonetics Corp's Enterprise Value for the quarter that ended in Dec. 2015 was $1,959.7 Mil.
Haemonetics Corp's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2015 was 11.538 (Mar. 2015 ) + 3.606 (Jun. 2015 ) + 19.179 (Sep. 2015 ) + -61.177 (Dec. 2015 ) = $-26.9 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Earnings Yield (Joel Greenblatt), Earnings Before Interest and Taxes (EBIT)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Haemonetics Corp Annual Data

Mar07Mar08Mar09Mar10Mar11Mar12Mar13Mar14Mar15Mar16
ev2ebit 14.1418.4515.0016.2613.5117.2043.0042.9863.85-47.21

Haemonetics Corp Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebit 48.8942.9840.2850.7453.5563.8552.9237.47-72.98-47.21
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK